News

Ozempic sales surge ‘up to 600%’ after Mounjaro price rises

Price hikes are 'kick in the teeth' for patients who will either have to swallow 170 per cent price increase, or switch to ...

Eli Lilly: A Textbook Insider Buying Play

Eli Lilly looks attractively valued, with P/E ratios well below historical averages and robust momentum in Zepbound and ...

Lilly’s Mounjaro Exhibits Heart Benefits In Type 2 Diabetes Landmark Trial

Eli Lilly and Company (NYSE:LLY) is among the 11 Best GLP-1 and Weight Loss Stocks to Invest in. Eli Lilly and Company ...

Voices: Pricing people out of using Mounjaro would be bad news for the NHS

COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous ...
FiercePharma18d

Mounjaro measures up to Trulicity in Eli Lilly cardio trial

Lilly has presented results from a phase 3 trial in which Mounjaro measures up head-to-head against the company’s GLP-1 Trulicity in reducing cardiovascular risks in patients with Type 2 ...

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Eli Lilly on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees ...

Cost of Mounjaro set to almost triple but people may still be able to get discounts

Mounjaro manufacturer Eli Lilly said it was raising the price by up to 170% which could hit people paying privately for the ...